ISO 13485

How to write medical device design verification test protocols covering scope, acceptance criteria, test methods, sample size justification, pass/fail criteria, and result documentation — aligned with FDA design control requirements, EU MDR technical documentation expectations, ISO 13485 Clause 7.3.7, and the FDA recommended content format for non-clinical bench testing reports.

How to validate adhesive bonding processes for medical devices — covering ISO 13485 Clause 7.5.6 and FDA QMSR requirements, UV curing and epoxy bonding process variables, IQ/OQ/PQ protocols, critical process parameters, surface preparation controls, adhesive chemistry selection (cyanoacrylate, UV-curable, epoxy, silicone), destructive testing strategy, revalidation triggers, and ongoing monitoring under FDA and EU MDR.

How to qualify a contract cleanroom assembly vendor for medical device manufacturing — cleanroom classification matching, environmental monitoring verification, gowning qualification, quality agreement requirements, audit approach, and ongoing oversight under ISO 13485, FDA QMSR, and EU MDR.

How to qualify a contract packaging vendor for medical device manufacturing — ISO 11607 validation capabilities, sterile barrier system expertise, seal process controls, labeling compliance, sterilization coordination, quality agreement requirements, and ongoing vendor oversight under ISO 13485, FDA QMSR, and EU MDR.

How to assign process validation ownership between OEM and CMO/CDMO for medical device manufacturing — protocol authorship, IQ/OQ/PQ execution responsibility, approval authority, and regulatory accountability under ISO 13485, FDA QMSR, and GHTF guidance.

How to draft ISO 13485 / QMSR-compliant supplier quality agreements for critical outsourced vendors — cloud hosting providers, AI model/data vendors, penetration testing firms, ASCA/non-ASCA test labs, and sterilization vendors — with clause-by-clause guidance, vulnerability notification clauses, audit rights, CAPA cooperation, change notification, and evidence records.

The medical device CDMO market is projected to grow from $134.65 billion in 2025 to $354.60 billion by 2033 at 13.12% CAGR. This guide covers market size, growth drivers, key players (Jabil, Integer, Flex, Plexus), M&A trends, and how to choose the right contract manufacturing partner.

Comprehensive supplier audit checklist for medical device manufacturers — covering supplier risk classification, qualification, audit agenda, purchasing controls per ISO 13485 Clause 7.4 and FDA QMSR, quality agreements, outsourced sterilization/testing/software, CAPA follow-up, and evidence records.

How to choose between Agile and Waterfall for medical device software development under IEC 62304 — AAMI TIR45 guidance, design control mapping, hybrid models, and what auditors actually look for.

How to select a medical device contract manufacturing organization — CMO evaluation criteria, quality agreement requirements under FDA 21 CFR 820 and ISO 13485, audit programs, change control, and step-by-step implementation checklist.

Complete guide to medical device design output documentation — what ISO 13485 Clause 7.3.4 and FDA 21 CFR 820.30(d) require for drawings, specifications, BOMs, acceptance criteria, and traceability to design inputs under QMSR.

Complete guide to medical device design review documentation — how to plan agendas, record minutes, ensure reviewer independence per FDA 21 CFR 820.30(e) and ISO 13485 Clause 7.3.5, and create audit-ready design review records under QMSR.

Complete guide to medical device design transfer — how to move from design to production under FDA 21 CFR 820.30(h), ISO 13485 Clause 7.3.8, and QMSR. Covers DMR readiness, process validation (IQ/OQ/PQ), supplier qualification, and audit-ready documentation.

Master batch manufacturing records (BMR), electronic batch records (EBR), and device history records (DHR) for medical device manufacturing. Covers 21 CFR 210/211, 21 CFR Part 820/QMSR, ISO 13485, paper vs electronic systems, review workflows, deviation management, and FDA inspection readiness.

How to calculate and reduce Cost of Quality in medical device manufacturing using the four-category model. Includes the 1-10-100 rule, McKinsey industry benchmarks (6.8–9.4% of sales), eQMS ROI data, and step-by-step implementation aligned with ISO 13485 and FDA QMSR.

How to transition from Computer System Validation (CSV) to Computer Software Assurance (CSA) under FDA's September 2025 final guidance — risk-based approach, testing strategies, documentation requirements, and step-by-step implementation roadmap.

How to manage Engineering Change Orders (ECOs) in medical device manufacturing — ECR to ECO to ECN workflow, ISO 13485 Clause 7.3.9 requirements, FDA QMSR design change control, risk assessment, regulatory notification triggers, and best practices for cross-functional approval.

How to build and manage an equipment calibration program for medical device manufacturing — ISO 13485 Clause 7.6 requirements, FDA QMSR compliance, NIST traceability, ISO 17025 accreditation, calibration schedules, out-of-tolerance procedures, and electronic calibration management.

Everything about the Person Responsible for Regulatory Compliance (PRRC) under EU MDR Article 15 — qualification pathways, responsibilities, small enterprise outsourcing rules, MDCG 2019-7 guidance, the 2025 simplification package removing rigid qualification thresholds, liability protections, EUDAMED registration, and practical implementation strategies.

How to prepare for FDA medical device inspections under the new QMSR framework (CP 7382.850) — inspection types, the six QMS areas, common 483 observations, and a step-by-step readiness checklist.